My NCBISign In
A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients
Laurel A Habel, Steven Shak, Marlena K Jacobs, Angela Capra, Claire Alexander, Mylan Pho, Joffre Baker, Michael Walker, Drew Watson, James Hackett, Noelle T Blick, Deborah Greenberg, Louis Fehrenbacher, Bryan Langholz, Charles P Quesenberry
Breast Cancer Res. 2006; 8(3): R25. Published online 2006 May 31. doi: 10.1186/bcr1412
PMCID:
PMC1557737
Abstract Full Text PDF–510K Supplementary Material

Is Cited by the Following 23 Articles in this Archive:

Early developments in gene-expression profiling of breast tumors: potential for increasing black–white patient disparities in breast cancer outcomes?
Donna H Odierna, Aimee Afable-Munsuz, Ogechi Ikediobi, Mary Beattie, Sara Knight, Michelle Ko, Adrienne Wilson, Ninez A Ponce
Per Med. Author manuscript; available in PMC 2012 September 1.
Published in final edited form as: Per Med. 2011 November; 8(6): 669–679. doi: 10.2217/pme.11.67
PMCID:
PMC3242007
Free in PMC on 2012/09/01
The Effect of Oncotype DX Recurrence Score on Treatment Recommendations for Patients with Estrogen Receptor–Positive Early Stage Breast Cancer and Correlation with Estimation of Recurrence Risk by Breast Cancer Specialists
Jennifer E. Joh, Nicole N. Esposito, John V. Kiluk, Christine Laronga, M. Catherine Lee, Loretta Loftus, Hatem Soliman, Judy C. Boughey, Carol Reynolds, Thomas J. Lawton, Peter I. Acs, Lucio Gordan, Geza Acs
Oncologist. 2011 November; 16(11): 1520–1526. Published online 2011 October 20. doi: 10.1634/theoncologist.2011-0045
PMCID:
PMC3233285
Free in PMC on 2012/11/01
Risk of Recurrence and Chemotherapy Benefit for Patients With Node-Negative, Estrogen Receptor–Positive Breast Cancer: Recurrence Score Alone and Integrated With Pathologic and Clinical Factors
Gong Tang, Jack Cuzick, Joseph P. Costantino, Mitch Dowsett, John F. Forbes, Michael Crager, Eleftherios P. Mamounas, Steven Shak, Norman Wolmark
J Clin Oncol. 2011 November 20; 29(33): 4365–4372. Published online 2011 October 17. doi: 10.1200/JCO.2011.35.3714
PMCID:
PMC3221521
Free in PMC on 2012/11/20
Do All Patients with Breast Cancer Require Systemic Adjuvant Therapy?
Jennifer J. Griggs, Daniel F. Hayes
J Natl Cancer Inst. 2011 September 21; 103(18): 1350–1351. Published online 2011 August 31. doi: 10.1093/jnci/djr331
PMCID:
PMC3176780
Free in PMC on 2012/09/21
Microarrays in the 2010s: the contribution of microarray-based gene expression profiling to breast cancer classification, prognostication and prediction
Pierre-Emmanuel Colombo, Fernanda Milanezi, Britta Weigelt, Jorge S Reis-Filho
Breast Cancer Res. 2011; 13(3): 212. Published online 2011 June 27. doi: 10.1186/bcr2890
PMCID:
PMC3218943
Abstract Full Text PDF–359K
Postoperative Fever: The Potential Relationship with Prognosis in Node Negative Breast Cancer Patients
Tingting Yan, Wenjin Yin, Liheng Zhou, Yiwei Jiang, Zhenzhou Shen, Zhimin Shao, Jinsong Lu
PLoS One. 2010; 5(12): e15903. Published online 2010 December 29. doi: 10.1371/journal.pone.0015903
PMCID:
PMC3012099
Abstract Full Text PDF–253K
Tumor Gene Expression Profiling in Women with Breast Cancer: Test Category: Prognostic
Cecelia Bellcross, W. David Dotson
PLoS Curr. 2010 September 2; 2: RRN1178. doi: 10.1371/currents.RRN1178
PMCID:
PMC2940139
Abstract Full Text
Unraveling human complexity and disease with systems biology and personalized medicine
Stephen Naylor, Jake Y Chen
Per Med. Author manuscript; available in PMC 2011 March 1.
Published in final edited form as: Per Med. 2010 May; 7(3): 275–289. doi: 10.2217/pme.10.16
PMCID:
PMC2888109
Abstract Full Text PDF–842K
Review of the Clinical Studies Using the 21-Gene Assay
Catherine M. Kelly, Ellen Warner, Daphne T. Tsoi, Sunil Verma, Kathleen I. Pritchard
Oncologist. 2010 May; 15(5): 447–456. Published online 2010 April 26. doi: 10.1634/theoncologist.2009-0277
PMCID:
PMC3227976
Abstract Full Text PDF–158K
Association Between the 21-Gene Recurrence Score Assay and Risk of Locoregional Recurrence in Node-Negative, Estrogen Receptor–Positive Breast Cancer: Results From NSABP B-14 and NSABP B-20
Eleftherios P. Mamounas, Gong Tang, Bernard Fisher, Soonmyung Paik, Steven Shak, Joseph P. Costantino, Drew Watson, Charles E. Geyer, Jr, D. Lawrence Wickerham, Norman Wolmark
J Clin Oncol. 2010 April 1; 28(10): 1677–1683. Published online 2010 January 11. doi: 10.1200/JCO.2009.23.7610
PMCID:
PMC2849763
Abstract Full Text PDF–264K
Prognostic and Predictive Value of the 21-Gene Recurrence Score Assay in a Randomized Trial of Chemotherapy for Postmenopausal, Node-Positive, Estrogen Receptor-Positive Breast Cancer
Kathy S. Albain, William E. Barlow, Steven Shak, Gabriel N. Hortobagyi, Robert B. Livingston, I-Tien Yeh, Peter Ravdin, Roberto Bugarini, Frederick L. Baehner, Nancy E. Davidson, George W. Sledge, Eric P. Winer, Clifford Hudis, James N. Ingle, Edith A. Perez, Kathleen I. Pritchard, Lois Shepherd, Julie R. Gralow, Carl Yoshizawa, D. Craig Allred, C. Kent Osborne, Daniel F. Hayes
Lancet Oncol. Author manuscript; available in PMC 2011 March 16.
Published in final edited form as: Lancet Oncol. 2010 January; 11(1): 55–65. Published online 2009 December 10. doi: 10.1016/S1470-2045(09)70314-6
PMCID:
PMC3058239
Abstract Full Text PDF–1.2M Supplementary Material
Alzheimer’s disease biomarker discovery in symptomatic and asymptomatic patients: Experimental approaches and future clinical applications
Lap Ho, Hayley Fivecoat, Jun Wang, Giulio Maria Pasinetti
Exp Gerontol. Author manuscript; available in PMC 2010 March 17.
Published in final edited form as: Exp Gerontol. 2010 January; 45(1): 15–22. Published online 2009 September 29. doi: 10.1016/j.exger.2009.09.007
PMCID:
PMC2840994
Abstract Full Text PDF–664K
Low expression of a few genes indicates good prognosis in estrogen receptor positive breast cancer
Steven Buechler
BMC Cancer. 2009; 9: 243. Published online 2009 July 20. doi: 10.1186/1471-2407-9-243
PMCID:
PMC2718903
Abstract Full Text PDF–1.0M
Comparison of Prognostic Gene Profiles Using qRT-PCR in Paraffin Samples: A Retrospective Study in Patients with Early Breast Cancer
Enrique Espinosa, Iker Sánchez-Navarro, Angelo Gámez-Pozo, Álvaro Pinto Marin, David Hardisson, Rosario Madero, Andrés Redondo, Pilar Zamora, Belén San José Valiente, Marta Mendiola, Manuel González Barón, Juan Ángel Fresno Vara
PLoS One. 2009; 4(6): e5911. Published online 2009 June 15. doi: 10.1371/journal.pone.0005911
PMCID:
PMC2698956
Abstract Full Text PDF–331K Supplementary Material
Recent advances in systemic therapy. New diagnostics and biological predictors of outcome in early breast cancer
Catherine Oakman, Silvia Bessi, Elena Zafarana, Francesca Galardi, Laura Biganzoli, Angelo Di Leo
Breast Cancer Res. 2009; 11(2): 205. Published online 2009 April 3. doi: 10.1186/bcr2238
PMCID:
PMC2688942
Abstract Full Text PDF–775K
Factors Influencing the Statistical Power of Complex Data Analysis Protocols for Molecular Signature Development from Microarray Data
Constantin F. Aliferis, Alexander Statnikov, Ioannis Tsamardinos, Jonathan S. Schildcrout, Bryan E. Shepherd, Frank E. Harrell, Jr.
PLoS ONE. 2009; 4(3): e4922. Published online 2009 March 17. doi: 10.1371/journal.pone.0004922
PMCID:
PMC2654113
Abstract Full Text PDF–277K Supplementary Material
A Radiation-Derived Gene Expression Signature Predicts Clinical Outcome for Breast Cancer Patients
Brian D. Piening, Pei Wang, Aravind Subramanian, Amanda G. Paulovich
Radiat Res. Author manuscript; available in PMC 2010 February 1.
Published in final edited form as: Radiat Res. 2009 February; 171(2): 141–154. doi: 10.1667/RR1223.1
PMCID:
PMC2662705
Abstract Full Text PDF–1.9M Supplementary Material
Genomancy: predicting tumour response to cancer therapy based on the oracle of genetics
P.D. Williams, J.K. Lee, D. Theodorescu
Curr Oncol. 2009 January; 16(1): 56–58.
PMCID:
PMC2644622
Abstract Full Text PDF–47K
Recommendations from the EGAPP Working Group: can tumor gene expression profiling improve outcomes in patients with breast cancer?
Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group
Genet Med. 2009 January; 11(1): 66–73.
PMCID:
PMC2743614
Abstract Full Text PDF–454K
Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
Yujin Hoshida, Augusto Villanueva, Masahiro Kobayashi, Judit Peix, Derek Y. Chiang, Amy Camargo, Supriya Gupta, Jamie Moore, Matthew J. Wrobel, Jim Lerner, Michael Reich, Jennifer A. Chan, Jonathan N. Glickman, Kenji Ikeda, Masaji Hashimoto, Goro Watanabe, Maria G. Daidone, Sasan Roayaie, Myron Schwartz, Swan Thung, Helga B. Salvesen, Stacey Gabriel, Vincenzo Mazzaferro, Jordi Bruix, Scott L. Friedman, Hiromitsu Kumada, Josep M. Llovet, Todd R. Golub
N Engl J Med. Author manuscript; available in PMC 2010 October 25.
Published in final edited form as: N Engl J Med. 2008 November 6; 359(19): 1995–2004. Published online 2008 October 15. doi: 10.1056/NEJMoa0804525
PMCID:
PMC2963075
Abstract Full Text PDF–1.0M Supplementary Material
Gene Expression Profiling of Breast Cancer
Ting Bao, Nancy E. Davidson
Adv Surg. Author manuscript; available in PMC 2009 November 10.
Published in final edited form as: Adv Surg. 2008; 42: 249–260. doi: 10.1016/j.yasu.2008.03.002
PMCID:
PMC2775529
Full Text PDF–1.0M
Is the thymidine labeling index a good prognostic marker in breast cancer?
Ebru Sen-Oran, Vahit Ozmen, Ayhan Bilir, Neslihan Cabioglu, Mahmut Muslumanoglu, Abdullah Igci, Nese Guney, Mustafa Kecer
World J Surg Oncol. 2007; 5: 93. Published online 2007 August 19. doi: 10.1186/1477-7819-5-93
PMCID:
PMC2000894
Abstract Full Text PDF–372K
An overview of prognostic factors for long-term survivors of breast cancer
Isabelle Soerjomataram, Marieke W. J. Louwman, Jacques G. Ribot, Jan A. Roukema, Jan Willem W. Coebergh
Breast Cancer Res Treat. 2008 February; 107(3): 309–330. Published online 2007 March 22. doi: 10.1007/s10549-007-9556-1
PMCID:
PMC2217620
Abstract Full Text PDF–320K
You are here: NCBI > Literature > PubMed Central (PMC)
Write to the Help Desk